IL6 and endothelial dysfunction: Hyperactivation of the immune response, including the release of pro-inflammatory cytokines such as interleukin-6 (IL-6), plays a key role in the pathophysiology of severe COVID-19 since IL-6 promotes endothelial dysfunction and the development of vascular permeability (3, 4).